{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:43:36Z","timestamp":1789155816970,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012286","name":"Deputy for Research and Technology, Kermanshah University of Medical Sciences","doi-asserted-by":"publisher","award":["3009512"],"award-info":[{"award-number":["3009512"]}],"id":[{"id":"10.13039\/501100012286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Previous caesarean scar pregnancy is one type of ectopic pregnancy in myometrium and fibrous tissue of previous caesarean scar. One of the therapeutic methods of this type of ectopic pregnancy is treatment with methotrexate. Given various findings on the treatment of caesarean scar pregnancy with methotrexate and lack of global report in this regard, we aimed to achieve a global report on the treatment of CSP with methotrexate through related literature review and analysis of the results of the studies, to enable more precise planning to reduce complications of CSP.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>This review study extracted information through searching national and international databases of SID\u060c, Embase, ScienceDirect, \u060c Scopus, \u060c PubMed, Web of Science (ISI) between 2003 and January 2020. To perform the meta-analysis, random-effects model and heterogeneity of the studies with I<jats:sup>2<\/jats:sup> index were investigated. Data were sanalysed using Comprehensive Meta-Analysis version 2.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 26 articles with a sample size of 600 individuals were enrolled in the meta-analysis. According to the results of the study, the mean level of \u03b2-hCG was 28,744.98\u2009\u00b1\u20094425.1 mIU\/ml before the intervention and was 23,836.78\u2009\u00b1\u20094533.1 mIU\/ml after the intervention. The mean intraoperative blood loss (ml) was 4.8\u2009\u00b1\u20093.76\u2009ml, mean hospital stay (days) was 11.7\u2009\u00b1\u20091.2\u2009days, mean time for serum-hCG normalization (days) was 41.6\u2009\u00b1\u20093.2\u2009days, success was 90.7% (95% CI: 86.7\u201393.5%), and complication was 9% (95% CI: 6.3\u201312.8%).<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The results of the current study show methotrexate significantly reduces \u03b2-hCG levels and can be effective in treating caesarean scar pregnancy and its complications.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12958-020-00666-0","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T10:06:02Z","timestamp":1604916362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Evaluation of treatment of previous cesarean scar pregnancy with methotrexate: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"18","author":[{"given":"Nader","family":"Salari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Kazeminia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamarina","family":"Shohaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anis al-Dawlah","family":"Nankali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5722-8300","authenticated-orcid":false,"given":"Masoud","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"issue":"3","key":"666_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0733-8627(03)00036-1","volume":"21","author":"D Della-Giustina","year":"2003","unstructured":"Della-Giustina D, Denny M. Ectopic pregnancy. Emerg Med Clin North Am. 2003 Aug;21(3):565\u201384.","journal-title":"Emerg Med Clin North Am"},{"issue":"8","key":"666_CR2","first-page":"1331","volume":"73","author":"T Benton","year":"2006","unstructured":"Benton T. Pain management is part of advance directives discussion. Am Fam Physician. 2006;73(8):1331.","journal-title":"Am Fam Physician"},{"issue":"5","key":"666_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/13645700600771942","volume":"15","author":"L Mettler","year":"2006","unstructured":"Mettler L, Sodhi B, Schollmeyer T, Mangeshikar P. Ectopic pregnancy treatment by laparoscopy, a short glimpse. Minim Invasive Ther Allied Technol. 2006;15(5):305\u201310.","journal-title":"Minim Invasive Ther Allied Technol"},{"issue":"3","key":"666_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0015-0282(98)00213-1","volume":"70","author":"PT Nieuwkerk","year":"1998","unstructured":"Nieuwkerk PT, Hajenius PJ, Van der Veen F, Ankum WM, Wijker W, Bossuyt PM. Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate. Fertil Steril. 1998;70(3):518\u201322.","journal-title":"Fertil Steril"},{"issue":"6","key":"666_CR5","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1097\/01.AOG.0000218690.24494.ce","volume":"107","author":"MA Rotas","year":"2006","unstructured":"Rotas MA, Haberman S, Levgur M. Cesarean scar ectopic pregnancies: etiology, diagnosis, and management. Obstet Gynecol. 2006;107(6):1373\u201381.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"666_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/uog.974","volume":"23","author":"KM Seow","year":"2004","unstructured":"Seow KM, Huang LW, Lin YH, Yan-Sheng Lin M, Tsai YL, Hwang JL. Cesarean scar pregnancy: issues in management. Ultrasound Obstet Gynecol. 2004;23(3):247\u201353.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"666_CR7","doi-asserted-by":"crossref","unstructured":"Nankali A, Ataee M, Shahlazadeh H, Daeichin S. Surgical management of the cesarean scar ectopic pregnancy: a case report. Case Rep Obstet Gynecol. 2013;2013:1\u20133.","DOI":"10.1155\/2013\/525187"},{"issue":"2","key":"666_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1471-0528.2001.00037.x","volume":"108","author":"MC Sowter","year":"2001","unstructured":"Sowter MC, Farquhar CM, Gudex G. An economic evaluation of single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured ectopic pregnancy. BJOG Int J Obstet Gynaecol. 2001;108(2):204\u201311.","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"9","key":"666_CR9","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1093\/humrep\/deg344","volume":"18","author":"P Rozenberg","year":"2003","unstructured":"Rozenberg P, Chevret S, Camus E, Tayrac R d, Garbin O, Poncheville L d, Coiffic J, Lucot JP, Goueff FL, Tardif D. Medical treatment of ectopic pregnancies: a srandomised clinical trial comparing methotrexate\u2013mifepristone and methotrexate\u2013placebo. Hum Reprod. 2003;18(9):1802\u20138.","journal-title":"Hum Reprod"},{"key":"666_CR10","doi-asserted-by":"crossref","unstructured":"Hajenius PJ, Mol F, Mol BWJ, Bossuyt PM, Ankum WM, Van der Veen F. Interventions for tubal ectopic pregnancy. Cochrane Database Syst Rev. 2007:1.","DOI":"10.1002\/14651858.CD000324.pub2"},{"issue":"10","key":"666_CR11","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1093\/oxfordjournals.humrep.a135774","volume":"10","author":"GH Corsan","year":"1995","unstructured":"Corsan GH, Karacan M, Qasim S, Bohrer MK, Ransom MX, Kemmann E. Identification of hormonal parameters for successful systemic single-dose methotrexate therapy in ectopic pregnancy. Hum Reprod. 1995;10(10):2719\u201322.","journal-title":"Hum Reprod"},{"issue":"6","key":"666_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1097\/00006250-199406000-00026","volume":"83","author":"MX Ransom","year":"1994","unstructured":"Ransom MX, Garcia AJ, Bohrer M, Corsan GH, Kemmann E. Serum progesterone as a predictor of methotrexate success in the treatment of ectopic pregnancy. Obstet Gynecol. 1994;83(6):1033\u20137.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"666_CR13","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/S0002-9378(98)70057-2","volume":"179","author":"M Perdu","year":"1998","unstructured":"Perdu M, Camus E, Rozenberg P, Goffinet F, Chastang C, Philippe H-J, Nisand I. Treating ectopic pregnancy with the combination of mifepristone and methotrexate: a phase II snonrandomised study. Am J Obstet Gynecol. 1998;179(3):640\u20133.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"666_CR14","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/S0002-9378(96)70219-3","volume":"174","author":"CS Stika","year":"1996","unstructured":"Stika CS, Anderson L, Frederiksen MC. Single-dose methotrexate for the treatment of ectopic pregnancy: northwestern memorial hospital three-year experience. Am J Obstet Gynecol. 1996;174(6):1840\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"666_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-8-18","volume":"8","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8(1):18.","journal-title":"BMC Med"},{"issue":"1","key":"666_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12884-018-1923-x","volume":"18","author":"S Wang","year":"2018","unstructured":"Wang S, Beejadhursing R, Ma X, Li Y. Management of Caesarean scar pregnancy with or without methotrexate before curettage: human chorionic gonadotropin trends and patient outcomes. BMC Pregnancy Child. 2018;18(1):289.","journal-title":"BMC Pregnancy Child"},{"key":"666_CR17","doi-asserted-by":"crossref","unstructured":"Giampaolino, P., N. De Rosa, I. Morra, A. Bertrando, A. Di Spiezio Sardo, B. Zizolfi, C. Ferrara, L. Della Corte and G. Bifulco (2018). \"Management of cesarean scar pregnancy: a single-institution retrospective review.\" BioMed research international 2018.","DOI":"10.1155\/2018\/6486407"},{"issue":"2","key":"666_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ejogrb.2011.01.016","volume":"156","author":"T Jiang","year":"2011","unstructured":"Jiang T, Liu G, Huang L, Ma H, Zhang S. Methotrexate therapy followed by suction curettage followed by Foley tamponade for caesarean scar pregnancy. Eur J Obstet Gynecol Reprod Biol. 2011;156(2):209\u201311.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"666_CR19","unstructured":"Shen, L., A. Tan, H. Zhu, C. Guo, D. Liu and W. Huang (2012). \u201cBilateral uterine artery schemoembolisation with methotrexate for cesarean scar pregnancy\u201d. Am J Obstet Gynecol 207(5): 386. e381\u2013386. e386."},{"issue":"4","key":"666_CR20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.tjog.2015.01.003","volume":"54","author":"F Qi","year":"2015","unstructured":"Qi F, Zhou W, Wang M-F, Chai Z-Y, Zheng L-Z. Uterine artery sembolisation with and without local methotrexate infusion for the treatment of cesarean scar pregnancy. Taiwanese J Obstet Gynecol. 2015;54(4):376\u201380.","journal-title":"Taiwanese J Obstet Gynecol"},{"issue":"2","key":"666_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijgo.2014.05.005","volume":"127","author":"L Gao","year":"2014","unstructured":"Gao L, Huang Z, Gao J, Mai H, Zhang Y, Wang X. Uterine artery sembolisation followed by dilation and curettage within 24 hours compared with systemic methotrexate for cesarean scar pregnancy. Int J Gynecol Obstet. 2014;127(2):147\u201351.","journal-title":"Int J Gynecol Obstet"},{"issue":"1","key":"666_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00404-015-3952-2","volume":"294","author":"W Liu","year":"2016","unstructured":"Liu W, Shen L, Wang Q, Wang W, Sun Z. Uterine artery sembolisation combined with curettage vs. methotrexate plus curettage for cesarean scar pregnancy. Arch Gynecol Obstet. 2016;294(1):71\u20136.","journal-title":"Arch Gynecol Obstet"},{"key":"666_CR23","doi-asserted-by":"crossref","unstructured":"Cao G-S, Liu R-Q, Liu Y-Y, Liu J-W, Li L-P, Zhang Q, Cao H-C, Li T-X. Menstruation recovery in scar pregnancy patients undergoing UAE and curettage and its influencing factors. Medicine. 2018;97(11):e9584.","DOI":"10.1097\/MD.0000000000009584"},{"issue":"3","key":"666_CR24","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3892\/etm.2016.3489","volume":"12","author":"Y Feng","year":"2016","unstructured":"Feng Y, Chen S, Li C, Zhang X, Duan H, Sooranna S, Johnson MR, Li J. Curettage after uterine artery sembolisation combined with methotrexate treatment for caesarean scar pregnancy. Exp Ther Med. 2016;12(3):1469\u201375.","journal-title":"Exp Ther Med"},{"issue":"2","key":"666_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3109\/13625187.2013.873400","volume":"19","author":"O Sevket","year":"2014","unstructured":"Sevket O, Keskin S, Ates S, Molla T, Dansuk R, Yazicioglu HF, Yucel O. Is methotrexate administration needed for the treatment of caesarean section scar pregnancy in addition to suction curettage? Eur J Contracept Reprod Health Care. 2014;19(2):128\u201333.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"666_CR26","doi-asserted-by":"crossref","unstructured":"Fadhlaoui, A., M. Khrouf, K. Kh\u00e9miri, K. Nouira, A. Chaker and F. Zhioua (2012). \u201cSuccessful conservative treatment of a cesarean scar pregnancy with systemically administered methotrexate and subsequent dilatation and curettage: a case report\u201d. Case reports in obstetrics and gynecology 2012.","DOI":"10.1155\/2012\/248564"},{"issue":"4","key":"666_CR27","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.fertnstert.2008.07.1780","volume":"92","author":"J-H Wang","year":"2009","unstructured":"Wang J-H, Xu K-H, Lin J, Xu J-Y, Wu R-J. Methotrexate therapy for cesarean section scar pregnancy with and without suction curettage. Fertil Steril. 2009;92(4):1208\u201313.","journal-title":"Fertil Steril"},{"issue":"4","key":"666_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/GMIT.GMIT_134_18","volume":"8","author":"IA Abdelazim","year":"2019","unstructured":"Abdelazim IA, Abu-Faza M, Zhurabekova G, Shikanova S, Kanshaiym S, Karimova B, Sarsembayev M, Starchenko T. Successful pregnancy outcome immediately after methotrexate treatment for cesarean section scar pregnancy. Gynecol Minimally Invasive Ther. 2019;8(4):185.","journal-title":"Gynecol Minimally Invasive Ther"},{"key":"666_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejogrb.2016.09.010","volume":"206","author":"SZ Uludag","year":"2016","unstructured":"Uludag SZ, Kutuk MS, Ak M, Ozgun MT, Dolanbay M, Aygen EM, Sahin Y. Comparison of systemic and local methotrexate treatments in cesarean scar pregnancies: time to change conventional treatment and follow-up protocols. Eur J Obstet Gynecol Reprod Biol. 2016;206:131\u20135.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"666_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/ajo.12273","volume":"55","author":"JK Ko","year":"2015","unstructured":"Ko JK, Li RH, Cheung VY. Caesarean scar pregnancy: a 10-year experience. Aust N Z J Obstet Gynaecol. 2015;55(1):64\u20139.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"7","key":"666_CR31","first-page":"1867","volume":"7","author":"X-H Yin","year":"2014","unstructured":"Yin X-H, Yang S-Z, Wang Z-Q, Jia H-Y, Shi M. Injection of MTX for the treatment of cesarean scar pregnancy: comparison between different methods. Int J Clin Exp Med. 2014;7(7):1867.","journal-title":"Int J Clin Exp Med"},{"issue":"5","key":"666_CR32","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/jog.12627","volume":"41","author":"T Cok","year":"2015","unstructured":"Cok T, Kalayci H, Ozdemir H, Haydardedeoglu B, Parlakgumus AH, Tarim E. Transvaginal ultrasound-guided local methotrexate administration as the first-line treatment for cesarean scar pregnancy: follow-up of 18 cases. J Obstet Gynaecol Res. 2015;41(5):803\u20138.","journal-title":"J Obstet Gynaecol Res"},{"issue":"4","key":"666_CR33","doi-asserted-by":"publisher","first-page":"601","DOI":"10.7863\/ultra.34.4.601","volume":"34","author":"IE Timor-Tritsch","year":"2015","unstructured":"Timor-Tritsch IE, Khatib N, Monteagudo A, Ramos J, Berg R, Kovacs S. Cesarean scar pregnancies: experience of 60 cases. J Ultrasound Med. 2015;34(4):601\u201310.","journal-title":"J Ultrasound Med"},{"issue":"5","key":"666_CR34","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.jmig.2014.03.024","volume":"21","author":"M Yamaguchi","year":"2014","unstructured":"Yamaguchi M, Honda R, Uchino K, Tashiro H, Ohba T, Katabuchi H. Transvaginal methotrexate injection for the treatment of cesarean scar pregnancy: efficacy and subsequent fecundity. J Minim Invasive Gynecol. 2014;21(5):877\u201383.","journal-title":"J Minim Invasive Gynecol"},{"issue":"2","key":"666_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00404-013-2765-4","volume":"288","author":"K-M Seow","year":"2013","unstructured":"Seow K-M, Wang P-H, Huang L-W, Hwang J-L. Transvaginal sono-guided aspiration of gestational sac concurrent with a local methotrexate injection for the treatment of unruptured cesarean scar pregnancy. Arch Gynecol Obstet. 2013;288(2):361\u20136.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"666_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ultrasmedbio.2011.10.012","volume":"38","author":"N Li","year":"2012","unstructured":"Li N, Zhu F, Fu S, Shi X. Transvaginal ultrasound-guided embryo aspiration plus local administration of low-dose methotrexate for caesarean scar pregnancy. Ultrasound Med Biol. 2012;38(2):209\u201313.","journal-title":"Ultrasound Med Biol"},{"issue":"3","key":"666_CR37","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/uog.56","volume":"21","author":"D Jurkovic","year":"2003","unstructured":"Jurkovic D, Hillaby K, Woelfer B, Lawrence A, Salim R, Elson C. First-trimester diagnosis and management of pregnancies implanted into the lower uterine segment cesarean section scar. Ultrasound Obstet Gynecol. 2003;21(3):220\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7","key":"666_CR38","first-page":"445","volume":"13","author":"R Pirjani","year":"2015","unstructured":"Pirjani R, Bayanni L, Shirazi M. Successful local and systemic medical treatment of cesarean scar pregnancy and a subsequent term pregnancy after treatment: a case series, Iran. J Reprod Med. 2015;13(7):445\u201350.","journal-title":"J Reprod Med"},{"key":"666_CR39","unstructured":"Fritz, M. A. and L. Speroff (2012). Clinical gynecologic endocrinology and infertility, lippincott Williams & wilkins."},{"issue":"18","key":"666_CR40","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1056\/NEJM200011023431807","volume":"343","author":"GH Lipscomb","year":"2000","unstructured":"Lipscomb GH, Stovall TG, Ling FW. Nonsurgical treatment of ectopic pregnancy. N Engl J Med. 2000;343(18):1325\u20139.","journal-title":"N Engl J Med"},{"issue":"4","key":"666_CR41","first-page":"778","volume":"101","author":"KT Barnhart","year":"2003","unstructured":"Barnhart KT, Gosman G, Ashby R, Sammel M. The medical management of ectopic pregnancy: a meta-analysis comparing \u201csingle dose\u201d and \u201cmultidose\u201d regimens. Obstet Gynecol. 2003;101(4):778\u201384.","journal-title":"Obstet Gynecol"},{"issue":"7","key":"666_CR42","first-page":"1005","volume":"27","author":"KB Soliman","year":"2006","unstructured":"Soliman KB, Saleh NM, Omran AA. Safety and efficacy of systemic methotrexate in the treatment of unruptured tubal pregnancy. Saudi Med J. 2006;27(7):1005.","journal-title":"Saudi Med J"},{"issue":"6","key":"666_CR43","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.ajog.2004.12.061","volume":"192","author":"GH Lipscomb","year":"2005","unstructured":"Lipscomb GH, Givens VM, Meyer NL, Bran D. Comparison of multidose and single-dose methotrexate protocols for the treatment of ectopic pregnancy. Am J Obstet Gynecol. 2005;192(6):1844\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"666_CR44","first-page":"57","volume":"12","author":"M Eskandar","year":"2007","unstructured":"Eskandar M. Single dose methotrexate for treatment of ectopic pregnancy: risk factors for treatment failure. Middle East Fertil Soc J. 2007;12(1):57.","journal-title":"Middle East Fertil Soc J"},{"issue":"4","key":"666_CR45","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/humupd\/dmn012","volume":"14","author":"F Mol","year":"2008","unstructured":"Mol F, Mol B, Ankum W, Van der Veen F, Hajenius P. Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis. Hum Reprod Update. 2008;14(4):309\u201319.","journal-title":"Hum Reprod Update"},{"issue":"03","key":"666_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1055\/s-2006-934097","volume":"23","author":"N Gabbur","year":"2006","unstructured":"Gabbur N, Sherer DM, Hellmann M, Abdelmalek E, Phillip P, Abulafia O. Do serum beta-human chorionic gonadotropin levels on day 4 following methotrexate treatment of patients with ectopic pregnancy predict successful single-dose therapy? Am J Perinatol. 2006;23(03):193\u20136.","journal-title":"Am J Perinatol"},{"issue":"4","key":"666_CR47","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00404-003-0543-4","volume":"270","author":"M Erdem","year":"2004","unstructured":"Erdem M, Erdem A, Arslan M, \u00d6\u00e7 A, Bibero\u011flu K, G\u00fcrsoy R. Single-dose methotrexate for the treatment of unruptured ectopic pregnancy. Arch Gynecol Obstet. 2004;270(4):201\u20134.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"666_CR48","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.fertnstert.2006.10.007","volume":"87","author":"S Menon","year":"2007","unstructured":"Menon S, Colins J, Barnhart KT. Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review. Fertil Steril. 2007;87(3):481\u20134.","journal-title":"Fertil Steril"},{"issue":"4","key":"666_CR49","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.fertnstert.2008.07.1775","volume":"92","author":"E Nowak-Markwitz","year":"2009","unstructured":"Nowak-Markwitz E, Michalak M, Olejnik M, Spaczynski M. Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy. Fertil Steril. 2009;92(4):1203\u20137.","journal-title":"Fertil Steril"},{"issue":"4","key":"666_CR50","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0015-0282(01)03256-3","volume":"77","author":"R Gamzu","year":"2002","unstructured":"Gamzu R, Almog B, Levin Y, Avni A, Jaffa A, Lessing JB, Baram A. Efficacy of methotrexate treatment in extrauterine pregnancies defined by stable or increasing human chorionic gonadotropin concentrations. Fertil Steril. 2002;77(4):761\u20135.","journal-title":"Fertil Steril"},{"key":"666_CR51","doi-asserted-by":"crossref","unstructured":"Luciano AA, Roy G, Solima E. Ectopic pregnancy: from surgical emergency to medical management. Annals of the New York Academy of Sciences. 2001;943(1):235\u201354.","DOI":"10.1111\/j.1749-6632.2001.tb03805.x"},{"key":"666_CR52","doi-asserted-by":"crossref","unstructured":"Marion LL, Rodney Meeks G. Ectopic pregnancy: History, incidence, epidemiology, and risk factors. Clin Obstet Gynecol. 2012;55(2):376\u201386.","DOI":"10.1097\/GRF.0b013e3182516d7b"},{"key":"666_CR53","unstructured":"Pietrzak Z. Ectopic pregnancy. II. Evaluation of the clinical value of a diagnostic algorithm for ectopic pregnancy. Ginekologia Polska. 2001;72(1):7\u201311."},{"key":"666_CR54","doi-asserted-by":"crossref","unstructured":"Nazac A, Gervaise A, Bouyer J, De Tayrac R, Capella\u2010Allouc S, Fernandez H. Predictors of success in methotrexate treatment of women with unruptured tubal pregnancies. Ultrasound in Obstetrics and Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2003;21(2):181\u20135.","DOI":"10.1002\/uog.9"},{"key":"666_CR55","unstructured":"Lewis-Bliehall C, Rogers RG, Kammerer-Doak DN, Conway SC, Amaya C, Byrn F. Medical vs. Surgical treatment of ectopic pregnancy. The University of New Mexico's six-year experience. Int J Reprod Med. 2001;46(11):983\u20138."},{"key":"666_CR56","doi-asserted-by":"crossref","unstructured":"Howard SC, McCormick J, Pui CHH, Buddington RK, Donald Harvey R. Preventing and Managing Toxicities of High-Dose Methotrexate. Oncologist.2016;21(12):1471\u201382.","DOI":"10.1634\/theoncologist.2015-0164"},{"key":"666_CR57","doi-asserted-by":"crossref","unstructured":"Bath RK, Brar NK, Forouhar FA, Wu GY. A review of methotrexate\u2010associated hepatotoxicity. J Dig Dis. 2014;15(10):517\u201324.","DOI":"10.1111\/1751-2980.12184"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-020-00666-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12958-020-00666-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-020-00666-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T14:05:57Z","timestamp":1605017157000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-020-00666-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["666"],"URL":"https:\/\/doi.org\/10.1186\/s12958-020-00666-0","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,9]]},"assertion":[{"value":"23 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval by the ethics committee of deputy for Research and Technology, Kermanshah University of Medical Sciences (IR) (3009512).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}